Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
55
# OF OVERLAPPING
HOLDINGS
BBP
57
HOLDINGS
90%
ALSO IN IBBQ
IBBQ
207
HOLDINGS
27%
ALSO IN BBP
SECTOR DRIFT (BBP minus IBBQ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.0% | 5.3% | 3.0% |
|
INSMED INC | 3.3% | 3.0% | 3.0% |
|
GILEAD SCIENCES INC | 2.1% | 7.4% | 2.1% |
|
UNITED THERAPEUTICS CORP | 1.8% | 1.8% | 1.8% |
|
AMGEN INC | 1.7% | 7.6% | 1.7% |
BBP Overweight Relative to IBBQ
|
MIRUM PHARMACEUTICALS, INC. | 2.6% |
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
SAGE THERAPEUTICS INC | 2.5% |
|
PHATHOM PHARMACEUTICALS, INC. | 2.5% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.3% |
|
BRIDGEBIO PHARMA, INC. | 2.3% |
 |
THERAVANCE BIOPHARMA INC | 2.3% |
|
LEXICON PHARMACEUTICALS, INC. | 2.1% |
|
LIGAND PHARMACEUTICALS-CL B | 2.1% |
BBP Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -6.2% |
|
AMGEN INC | -5.9% |
|
GILEAD SCIENCES INC | -5.3% |
|
REGENERON PHARMACEUTICALS | -4.3% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
ALNYLAM PHARMACEUTICALS INC | -2.3% |
 |
ARGENX SE ADR | -2.2% |
|
SUMMIT THERAPEUTICS INC | -1.4% |
|
ILLUMINA INC | -1.4% |
|
ROYALTY PHARMA PLC CLASS A | -1.4% |